Pricing Log in Create free account
Friday 6 November 2026 Export TAK’s income statement to Excel — free account

Takeda Pharmaceutical Co.

TAK Healthcare Drug Manufacturers Specialty & Generic

Takeda Pharmaceutical Co.’s revenue for fiscal 2026 (year ended March 2026) was $29.7 billion, down 1.66% from fiscal 2025.

Revenue
+1.71%
EPS
−4.35%
Free cash flow
+54.9%
Total debt
−7.28%

Quarter to September 2026, against a year earlier

21.25 0.19 +0.90%
Market cap
$67.7B
P/E
32.0×
Fwd P/E
—
Dividend yield
1.45%
F-score
4/9
Altman Z
1.03
Beneish M
−2.65
Dividend safety
25/100
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Takeda Pharmaceutical Co. (TAK) EV/FCF

Alert me on EV/FCF

As of 5 November 2026, Takeda Pharmaceutical Co. (TAK) trades at a EV/FCF of 11.7×. Over the past ten years it has ranged from −102× (January 2024) to 72.7× (October 2023); the current reading is higher than 70% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2026 7.8× (29.72%)
FY2025 11.1× (74.45%)
FY2024 43.3× 38.79%
FY2023 31.2× 244.37%
FY2022 9.1× (23.37%)
FY2021 11.8× (42.68%)
FY2020 20.6× 279.00%
FY2019 5.4× 17.55%
FY2018 4.6× 10.00%
FY2017 4.2× 6.60%

Quarterly newest first

Period EV/FCF Change
Jun 2026 10.6× (12.69%)
Jun 2025 12.1× (45.22%)
Jun 2024 22.1× (48.93%)
Mar 2024 43.3× —
25 more quarters

Against its own ten years

Low −102× High 72.7×
Ten-year median 9.8×
Current reading's percentile 66

EV/FCF against peers

Company EV/FCF
HLN Haleon PLC Sponsored ADR compare 11.4×
TAK Takeda Pharmaceutical Co. 11.7×
NBIX Neurocrine Biosciences, Inc. compare 15.5×
VTRS Viatris Inc. compare 16.3×
ZTS Zoetis Inc. compare 18.4×
UTHR United Therapeutics Corporation compare 24.2×
ELAN Elanco Animal Health Incorporated compare 42.7×
TEVA Teva Pharmaceutical Industries Ltd. compare 46.2×
RDY Dr. Reddy's Laboratories Ltd compare 126×

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on TAK